A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic

Genome Research

Volumn 23, Issue 4, 2013, Pages 653-664

  Holden, Matthew T G ^a   Hsu, Li Yang ^a,b   Kurt, Kevin ^c   Weinert, Lucy A ^d,u   Mather, Alison E ^a   Harris, Simon R ^a   Strommenger, Birgit ^c   Layer, Franziska ^c   Witte, Wolfgang ^c   De Lencastre, Herminia ^e,f   Skov, Robert ^g   Westh, Henrik ^h,i   Žemličková, Helena ^j   Coombs, Geoffrey ^k   Kearns, Angela M ^l   Hill, Robert L R ^l   Edgeworth, Jonathan ^m   Gould, Ian ⁿ   Gant, Vanya ^o   Cooke, Jonathan ^d   Edwards, Giles F ^p   McAdam, Paul R ^q   Templeton, Kate E ^r   McCann, Angela ^s   Zhou, Zhemin ^s   Castillo Ramírez, Santiago ^t   Feil, Edward J ^t   Hudson, Lyndsey O ^d   Enright, Mark C ^d,v   Balloux, Francois ^d,w   Aanensen, David M ^d   Spratt, Brian G ^d   Fitzgerald, J Ross ^q   Parkhill, Julian ^a   Achtman, Mark ^s   Bentley, Stephen D ^a   Nübel, Ulrich ^c   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c ROBERT KOCH INSTITUTE   (Germany)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^f ROCKEFELLER UNIVERSITY   (United States)

^g STATENS SERUM INSTITUT   (Denmark)

^h HVIDOVRE HOSPITAL   (Denmark)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^k ROYAL PERTH HOSPITAL   (Australia)

^l PUBLIC HEALTH ENGLAND   (United Kingdom)

^m KING'S COLLEGE LONDON   (United Kingdom)

ⁿ ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^o UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^p STOBHILL HOSPITAL   (United Kingdom)

^q UNIVERSITY OF EDINBURGH   (United Kingdom)

^r ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^s UNIVERSITY COLLEGE CORK   (Ireland)

^t University of Bath   (United Kingdom)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v UNIVERSITY OF BATH   (United Kingdom)

^w UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; INTEGRIN; OXAZOLIDINONE DERIVATIVE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG RESISTANCE; GENE SEQUENCE; GENOMICS; GENOTYPE; HOSPITAL INFECTION; HUMAN; INTERNALIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR GENETICS; PANDEMIC; PHENOTYPE; PHYLOGENY; PHYLOGEOGRAPHY; PRIORITY JOURNAL; TRANSPOSON; UNITED KINGDOM;

CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; GENOME, BACTERIAL; GENOMICS; GENOTYPE; GREAT BRITAIN; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PANDEMICS; PHYLOGENY; PHYLOGEOGRAPHY; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84875741847     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.147710.112     Document Type: Article

References (109)

1. Aires-de-Sousa M, Correia B, de Lencastre H. 2008. Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: Surveillance over a 16-year period. J Clin Microbiol 46: 2912-2917.
2. Albers CA, Lunter G, MacArthur DG, McVean G, Ouwehand WH, Durbin R. 2011. Dindel: Accurate indel calls from short-read data. Genome Res 21: 961-973.
3. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215: 403-410.
4. Amorim ML, Faria NA, Oliveira DC, Vasconcelos C, Cabeda JC, Mendes AC, Calado E, Castro AP, Ramos MH, Amorim JM, et al. 2007. Changes in the clonal nature and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus isolates associated with spread of the EMRSA-15 clone in a tertiary care Portuguese hospital. J ClinMicrobiol 45: 2881-2888.
5. Arakere G, Nadig S, Swedberg G, Macaden R, Amarnath SK, Raghunath D. 2005. Genotyping of methicillin-resistant Staphylococcus aureus strains from two hospitals in Bangalore, South India. J Clin Microbiol 43: 3198-3202.
6. Ausubel FM, Brent R, Kingston RB, Moore DD, Seidman JG, Smith JA, Struhl K. 1995. In Current protocols in molecular biology. JohnWiley & Sons, New York.
7. Bergeron MG, Ouellette M. 1998. Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory. J Clin Microbiol 36: 2169-2172.
8. Carver TJ, Rutherford KM, Berriman M, RajandreamMA, Barrell BG, Parkhill J. 2005.ACT: TheArtemis Comparison Tool. Bioinformatics 21: 3422-3423.
9. Catchpole I, Thomas C, Davies A, Dyke KG. 1988. The nucleotide sequence of Staphylococcus aureus plasmid pT48 conferring inducible macrolidelincosamide- streptogramin B resistance and comparison with similar plasmids expressing constitutive resistance. J Gen Microbiol 134: 697-709.
10. Chambers HF, Deleo FR. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7: 629-641.
11. Chen HJ, Hung WC, Tseng SP, Tsai JC, Hsueh PR, Teng LJ. 2010. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother 54: 4985-4991.
12. Clarke SR, Harris LG, Richards RG, Foster SJ. 2002. Analysis of Ebh, a 1.1- megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. Infect Immun 70: 6680-6687.
13. Clewell DB, An FY, White BA, Gawronburke C. 1985. Streptococcus faecalis sex-pheromone (cAM373) also produced by Staphylococcus aureus and identification of a conjugative transposon (Tn918). J Bacteriol 162: 1212-1220.
14. Coenen S, Ferech M, Malhotra-Kumar S, Hendrickx E, Suetens C, Goossens H. 2006. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 58: 418-422.
15. Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, McGee L, von Gottberg A, Song JH, Ko KS, et al. 2011. Rapid pneumococcal evolution in response to clinical interventions. Science 331: 430-434.
16. Crump B,Wise R, Dent J. 1983. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother 24: 784-786.
17. deWith K, KernWV, Meyer E. 2011. Antibiotikaverbrauch im Krankenhaus. In GERMAP 2010 Antibiotika-Resistenz und -Verbrauch, pp. 17-21. Düsseldorf, Germany.
18. DeLeo FR, Kennedy AD, Chen L, Bubeck Wardenburg J, Kobayashi SD, Mathema B, Braughton KR, Whitney AR, Villaruz AE, Martens CA, et al. 2011. Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci 108: 18091-18096.
19. Deutsches Institut fuer Normung. 2007. DIN 58940. Medical microbiology- susceptibility testing of pathogens to antimicrobial agents. Part 8. Microdilution. In DIN-Taschenbuch 222: Medizinische Mikrobiologie und Immunologie-Diagnostische Verfahren. Beuth-Verlag, Berlin, Germany.
20. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, et al. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367: 731-739.
21. Drummond AJ, Pybus OG, Rambaut A, Forsberg R, Rodrigo AG. 2003. Measurably evolving populations. Trends Ecol Evol 18: 481-488.
22. Drummond AJ, SuchardMA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29: 1969-1973.
23. Edwards CJ, Suchard MA, Lemey P, Welch JJ, Barnes I, Fulton TL, Barnett R, O'Connell TC, Coxon P, Monaghan N, et al. 2011. Ancient hybridization and an Irish origin for the modern polar bear matriline. Curr Biol 21: 1251-1258.
24. Edwards AM, Massey RC, Clarke SR. 2012. Molecular mechanisms of Staphylococcus aureus nasopharyngeal colonization. Mol Oral Microbiol 27: 1-10.
25. Ellington MJ, Hope R, Livermore DM, Kearns AM, Henderson K, Cookson BD, Pearson A, Johnson AP. 2010. Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. J Antimicrob Chemother 65: 446-448.
26. Enright AJ, Van Dongen S, Ouzounis CA. 2002. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res 30: 1575-1584.
27. Eyre DW, Golubchik T, Gordon NC, Bowden R, Piazza P, Batty EM, Ip CL, Wilson DJ, Didelot X, O'Connor L, et al. 2012. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2: e001124.
28. Feil EJ, Cooper JE, Grundmann H, Robinson DA, Enright MC, Berendt T, Peacock SJ, Smith JM, Murphy M, Spratt BG, et al. 2003. How clonal is Staphylococcus aureus? J Bacteriol 185: 3307-3316.
29. Finch R, Whitby M, Craddock C, Holliday A, Martin J, Pilkington R. 1986. Clinical evaluation of treatment with Ciprofloxacin. Eur J Clin Microbiol Infect Dis 5: 257-259.
30. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. 2001. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 39: 3727-3732.
31. Fowler T, Wann ER, Joh D, Johansson S, Foster TJ, Hook M. 2000. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell b1 integrins. Eur J Cell Biol 79: 672-679.
32. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, Paulsen IT, Kolonay JF, Brinkac L, Beanan M, et al. 2005. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilmproducing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol 187: 2426-2438.
33. Gomes AR, Vinga S, Zavolan M, de Lencastre H. 2005. Analysis of the genetic variability of virulence-related loci in epidemic clones of methicillinresistant Staphylococcus aureus. Antimicrob Agents Chemother 49: 366-379.
34. Greene C, McDevitt D, Francois P, Vaudaux PE, Lew DP, Foster TJ. 1995. Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes. Mol Microbiol 17: 1143-1152.
35. Griggs DJ, Marona H, Piddock LJ. 2003. Selection of moxifloxacin- resistant Staphylococcus aureus compared with five other fluoroquinolones. J Antimicrob Chemother 51: 1403-1407.
36. Grundmann H, Aanensen DM, van denWijngaard CC, Spratt BG, Harmsen D, Friedrich AW. 2010. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: A molecular-epidemiological analysis. PLoS Med 7: e1000215.
37. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, Gardete S, Tavares A, Day N, Lindsay JA, et al. 2010. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327: 469-474.
38. Harris SR, Cartwright EJ, Torok ME, Holden MT, Brown NM, Ogilvy-Stuart AL, Ellington MJ, Quail MA, Bentley SD, Parkhill J, et al. 2012.Wholegenome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: A descriptive study. Lancet Infect Dis 13: 130-136.
39. Hasegawa M, Kishino H, Yano T. 1985. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 22: 160-174.
40. Hawkey PM. 1997. Quinolones in sweat and quinolone resistance. Lancet 349: 148-149.
41. Hodgson JE, Curnock SP, Dyke KG, Morris R, Sylvester DR, Gross MS. 1994. Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870. Antimicrob Agents Chemother 38: 1205-1208.
42. Holden MTG, Feil EJ, Lindsay JA, Peacock SJ, Day NPJ, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, et al. 2004. Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci 101: 9786-9791.
43. HoldenMT, Lindsay JA, Corton C, Quail MA, Cockfield JD, Pathak S, Batra R, Parkhill J, Bentley SD, Edgeworth JD. 2010. Genome sequence of a recently emerged, highly transmissible, multi-antibiotic- and antiseptic-resistant variant ofmethicillin-resistant Staphylococcus aureus, sequence type 239 (TW). J Bacteriol 192: 888-892.
44. Holtfreter S, Grumann D, Schmudde M, Nguyen HT, Eichler P, Strommenger B, Kopron K, Kolata J, Giedrys-Kalemba S, Steinmetz I, et al. 2007. Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol 45: 2669-2680.
45. Hori S, Sunley R, Tami A, Grundmann H. 2002. The Nottingham Staphylococcus aureus population study: Prevalence of MRSA among the elderly in a university hospital. J Hosp Infect 50: 25-29.
46. Hsu LY, Koh TH, Singh K, Kang ML, Kurup A, Tan BH. 2005. Dissemination of multisusceptible methicillin-resistant Staphylococcus aureus in Singapore. J Clin Microbiol 43: 2923-2925.
47. Hyatt D, Chen GL, Locascio PF, Land ML, Larimer FW, Hauser LJ. 2010. Prodigal: Prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics 11: 119.
48. Johnson AP, Aucken HM, Cavendish S, Ganner M, Wale MC, Warner M, Livermore DM, Cookson BD. 2001. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: Analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother 48: 143-144.
49. Jones RN, Kohno S, Ono Y, Ross JE, Yanagihara K. 2009. ZAAPS International Surveillance Program (2007) for linezolid resistance: Results from 5591 Gram-positive clinical isolates in 23 countries. Diagn Microbiol Infect Dis 64: 191-201.
50. Keim PS,Wagner DM. 2009. Humans and evolutionary and ecological forces shaped the phylogeography of recently emerged diseases. Nat Rev Microbiol 7: 813-821.
51. Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, Mediavilla JR, Byrne KA, Parkins LD, Tenover FC, et al. 2008. Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification. Proc Natl Acad Sci 105: 1327-1332.
52. Khan SA, Novick RP. 1983. Complete nucleotide sequence of pT181, a tetracycline-resistance plasmid from Staphylococcus aureus. Plasmid 10: 251-259.
53. Klein E, Smith DL, Laxminarayan R. 2007. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 13: 1840-1846.
54. Ko KS, Lee JY, Suh JY,OhWS, Peck KR, Lee NY, Song JH. 2005. Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries. J Clin Microbiol 43: 421-426.
55. Köser CU, Holden MTG, Elllington MJ, Cartwright EJP, Brown NM, Ogilvy- Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, et al. 2012. A neonatal MRSA outbreak investigation using rapid whole genome sequencing. N Engl J Med 366: 2267-2275.
56. Kuhn G, Koessler T, Melles DC, Francois P, Huyghe A, Dunman P, Vos MC, Zanetti G, Schrenzel J, van Belkum A, et al. 2010. Comparative genomics of epidemic versus sporadic Staphylococcus aureus strains does not reveal molecular markers for epidemicity. Infect Genet Evol 10: 89-96.
57. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui LZ, Oguchi A, Aoki K, Nagai Y, et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357: 1225-1240.
58. Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM. 2012. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: A 10 year study. J Antimicrob Chemother 67: 1010-1015.
59. Leelaporn A, Firth N, Byrne ME, Roper E, Skurray RA. 1994. Possible role of insertion sequence IS257 in dissemination and expression of high- and low-level trimethoprim resistance in staphylococci. Antimicrob Agents Chemother 38: 2238-2244.
60. Lemey P, Rambaut A, Drummond AJ, Suchard MA. 2009. Bayesian phylogeography finds its roots. PLoS Comput Biol 5: e1000520.
61. Lemey P, Rambaut A, Welch JJ, Suchard MA. 2010. Phylogeography takes a relaxed random walk in continuous space and time. Mol Biol Evol 27: 1877-1885.
62. Levin TP, Suh B, Axelrod P, Truant AL, Fekete T. 2005. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: Report of a clinical failure. Antimicrob Agents Chemother 49: 1222-1224.
63. Li M, Du X, Villaruz AE, Diep BA, Wang D, Song Y, Tian Y, Hu J, Yu F, Lu Y, et al. 2012. MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat Med 18: 816-819.
64. Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, Heltzel D, Ray SM, Harrison LH, Lynfield R, et al. 2009. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: A population-based analysis. J Clin Microbiol 47: 1344-1351.
65. Linde H,Wagenlehner F, Strommenger B, Drubel I, Tanzer J, Reischl U, Raab U, Holler C, Naber KG, Witte Wet al. 2005. Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany. Eur J Clin Microbiol Infect Dis 24: 419-422.
66. Lindsay JA, Holden MTG. 2004. Staphylococcus aureus: Superbug, super genome? Trends Microbiol 12: 378-385.
67. Livermore DM, James D, Reacher M, Graham C, Nichols T, Stephens P, Johnson AP, George RC. 2002. Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis 8: 473-478.
68. Locke JB, Hilgers M, Shaw KJ. 2009. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother 53: 5265-5274.
69. Lowder BV, Guinane CM, Ben Zakour NL, Weinert LA, Conway-Morris A, Cartwright RA, Simpson AJ, Rambaut A, Nubel U, Fitzgerald Jr. 2009. Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus. Proc Natl Acad Sci 106: 19545-19550.
70. McAdam P, Templeton K, Edwards GF, Holden MTG, Feil EJ, Aanensen DM, Bargawi H, Spratt BG, Bentley SD, Parkhill J, et al. 2012. Molecular tracing of the emergence, adaptation and transmission of hospitalassociated MRSA. Proc Natl Acad Sci 109: 9107-9112.
71. Melter O, Urbaskova P, Jakubu V, Mackova B, Zemlickova H 2006. Emergence of EMRSA-15 clone in hospitals throughout the Czech Republic. Euro Surveill 11: E060803.6.
72. Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD. 2006. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): A summary of the data from 2001 through 2004. Infection 34: 303-309.
73. Milheirico C, Oliveira DC, de Lencastre H. 2007. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: 'SCCmec IV multiplex.' J Antimicrob Chemother 60: 42-48.
74. Novick RP. 2003. Mobile genetic elements and bacterial toxinoses: The superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 49: 93-105.
75. Nübel U, Roumagnac P, Feldkamp M, Song JH, Ko KS, Huang YC, Coombs G, Ip M, Westh H, Skov R, et al. 2008. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci 105: 14130-14135.
76. Nübel U, Dordel J, Kurt K, Strommenger B,Westh H, Shukla SK, Zemlickova H, Leblois R, Wirth T, Jombart T, et al. 2010. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog 6: e1000855.
77. Olsen RJ, Sitkiewicz I, Ayeras AA, Gonulal VE, Cantu C, Beres SB, Green NM, Lei B, Humbird T, Greaver J, et al. 2010. Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci 107: 888-893.
78. O'Neill AJ, McLaws F, Kahlmeter G, Henriksen AS, Chopra I. 2007. Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother 51: 1737-1740.
79. Parienti JJ, Cattoir V, Thibon P, Lebouvier G, Verdon R, Daubin C, du Cheyron D, Leclercq R, Charbonneau P. 2011. Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: A 10-year interrupted time-series analysis. J Hosp Infect 78: 118-122.
80. Peacock SJ, Day NP, Thomas MG, Berendt AR, Foster TJ. 2000. Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin. J Infect 41: 23-31.
81. Pearman JW, Coombs GW, Grubb WB, O'Brien F. 2001. A British epidemic strain of methicillin-resistant Staphylococcus aureus (UK EMRSA-15) in Western Australia. Med J Aust 174: 662.
82. Phillips S, Novick RP. 1979. Tn554 - a site-specific repressor-controlled transposon in Staphylococcus aureus. Nature 278: 476-478.
83. Richardson JF, Reith S. 1993. Characterization of a strain of methicillinresistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J Hosp Infect 25: 45-52.
84. Robinson DA, Enright MC. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47: 3926-3934.
85. Roche FM, Downer R, Keane F, Speziale P, Park PW, Foster TJ. 2004. The N-terminal A domain of fibronectin-binding proteins A and B promotes adhesion of Staphylococcus aureus to elastin. J Biol Chem 279: 38433-38440.
86. Rouch DA, Byrne ME, Kong YC, Skurray RA. 1987. The aacA-aphD gentamicin and kanamycin resistance determinant of Tn4001 from Staphylococcus aureus: Expression and nucleotide sequence analysis. J Gen Microbiol 133: 3039-3052.
87. Rouch DA, Messerotti LJ, Loo LS, Jackson CA, Skurray RA. 1989. Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257. Mol Microbiol 3: 161-175.
88. Rowland SJ, Dyke KGH. 1989. Characterization of the staphylococcal b-lactamase transposon Tn552. EMBO J 8: 2761-2773.
89. Ruimy R, Armand-Lefevre L, Barbier F, Ruppe E, Cocojaru R, Mesli Y, Maiga A, Benkalfat M, Benchouk S, Hassaine H, et al. 2009. Comparisons between geographically diverse samples of carried Staphylococcus aureus. J Bacteriol 191: 5577-5583.
90. Sako T, Tsuchida N. 1983. Nucleotide sequence of the staphylokinase gene from Staphylococcus aureus. Nucleic Acids Res 11: 7679-7693.
91. Salangsang JA, Harrison LH, Brooks MM, Shutt KA, SaulMI,Muto CA. 2010. Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Infect Control Hosp Epidemiol 31: 1139-1147.
92. Shinji H, Yosizawa Y, Tajima A, Iwase T, Sugimoto S, Seki K, Mizunoe Y. 2011. Role of fibronectin-binding proteins A and B in in vitro cellular infections and in vivo septic infections by Staphylococcus aureus. Infect Immun 79: 2215-2223.
93. Silverman SH, Johnson M, Burdon DW, Keighley MRB. 1986. Pharmacokinetics of single dose intravenous Ciprofloxacin in patients undergoing gastrointestinal surgery. J Antimicrob Chemother 18: 107-112.
94. Smyth DS, Robinson DA. 2009. Integrative and sequence characteristics of a novel genetic element, ICE6013, in Staphylococcus aureus. J Bacteriol 191: 5964-5975.
95. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, Segre JA. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4: 148ra116.
96. Sola C, Saka HA, Vindel A, Bocco JL. 2008. Emergence and dissemination of a community-associated methicillin-resistant Panton-Valentine leucocidin-positive Staphylococcus aureus clone sharing the sequence type 5 lineage with the most prevalent nosocomial clone in the same region of Argentina. J Clin Microbiol 46: 1826-1831.
97. Stamatakis A, Ludwig T, Meier H. 2005. RAxML-III: A fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21: 456-463.
98. Strommenger B, Braulke C, Heuck D, Schmidt C, Pasemann B, Nübel U, Witte W. 2008. Spa-typing of Staphylococcus aureus as a frontline tool in epidemiological typing. J Clin Microbiol 46: 574-581.
99. Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR, Persing DH. 2011. Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents Chemother 56: 1324-1330.
100. Utsui Y, Yokota T. 1985. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother 28: 397-403.
101. van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA. 2006. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on b-hemolysin-converting bacteriophages. J Bacteriol 188: 1310-1315.
102. Voladri RK, Kernodle DS. 1998. Characterization of a chromosomal gene encoding type B b-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob Agents Chemother 42: 3163-3168.
103. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. 2003. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9: 1415-1422.
104. Weisblum B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother 39: 797-805.
105. Witte W, Enright M, Schmitz FJ, Cuny C, Braulke C, Heuck D. 2001. Characteristics of a new epidemic MRSA in Germany ancestral to United Kingdom EMRSA 15. Int J Med Microbiol 290: 677-682.
106. Witte W, Strommenger B, Cuny C, Heuck D, Nuebel U. 2007. Methicillinresistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 60: 1258-1263.
107. Witte W, Cuny C, Klare I, Nubel U, Strommenger B, Werner G. 2008. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens. Int J Med Microbiol 298: 365-377.
108. Woodford N, Livermore DM. 2009. Infections caused by Gram-positive bacteria: A review of the global challenge. J Infect (Suppl 1) 59: S4-S16.
109. Zerbino DR, Birney E. 2008. Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18: 821-829.